Author:
Yuan Lei,Ji Mengyao,Wang Shuo,Wen Xinyu,Huang Pingxiao,Shen Lei,Xu Jun
Abstract
Abstract
Background
Acute pancreatitis (AP) with critical illness is linked to increased morbidity and mortality. Current risk scores to identify high-risk AP patients have certain limitations.
Objective
To develop and validate a machine learning tool within 48 h after admission for predicting which patients with AP will develop critical illness based on ubiquitously available clinical, laboratory, and radiologic variables.
Methods
5460 AP patients were enrolled. Clinical, laboratory, and imaging variables were collected within 48 h after hospital admission. Least Absolute Shrinkage Selection Operator with bootstrap method was employed to select the most informative variables. Five different machine learning models were constructed to predictive likelihood of critical illness, and the optimal model (APCU) was selected. External cohort was used to validate APCU. APCU and other risk scores were compared using multivariate analysis. Models were evaluated by area under the curve (AUC). The decision curve analysis was employed to evaluate the standardized net benefit.
Results
Xgboost was constructed and selected as APCU, involving age, comorbid disease, mental status, pulmonary infiltrates, procalcitonin (PCT), neutrophil percentage (Neu%), ALT/AST, ratio of albumin and globulin, cholinesterase, Urea, Glu, AST and serum total cholesterol. The APCU performed excellently in discriminating AP risk in internal cohort (AUC = 0.95) and external cohort (AUC = 0.873). The APCU was significant for biliogenic AP (OR = 4.25 [2.08–8.72], P < 0.001), alcoholic AP (OR = 3.60 [1.67–7.72], P = 0.001), hyperlipidemic AP (OR = 2.63 [1.28–5.37], P = 0.008) and tumor AP (OR = 4.57 [2.14–9.72], P < 0.001). APCU yielded the highest clinical net benefit, comparatively.
Conclusion
Machine learning tool based on ubiquitously available clinical variables accurately predicts the development of AP, optimizing the management of AP.
Publisher
Springer Science and Business Media LLC
Subject
Health Informatics,Health Policy,Computer Science Applications
Reference42 articles.
1. Pavlidis P, Crichton S, Lemmich Smith J, Morrison D, Atkinson S, Wyncoll D, Ostermann M. Improved outcome of severe acute pancreatitis in the intensive care unit. Crit Care Res Pract. 2013;2013:897107.
2. Lankisch PG, Apte M, Banks PA. Acute pancreatitis. Lancet. 2015;386:85–96.
3. Yasuda H, Horibe M, Sanui M, Sasaki M, Suzuki N, Sawano H, Goto T, Ikeura T, Takeda T, Oda T, et al. Etiology and mortality in severe acute pancreatitis: a multicenter study in Japan. Pancreatology. 2020;20:307–17.
4. Petrov MS, Pylypchuk RD, Uchugina AF. A systematic review on the timing of artificial nutrition in acute pancreatitis. Br J Nutr. 2009;101:787–93.
5. Corfield AP, Cooper MJ, Williamson RC, Mayer AD, McMahon MJ, Dickson AP, Shearer MG, Imrie CW. Prediction of severity in acute pancreatitis: prospective comparison of three prognostic indices. Lancet. 1985;2:403–7.